Application of targeted drug delivery by cell membrane-based biomimetic nanoparticles for inflammatory diseases and cancers.
Biomimetic nanoparticle
Cancer
Cell membrane
Inflammatory diseases
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
received:
02
08
2024
accepted:
23
10
2024
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
epublish
Résumé
Drug-carrying nanoparticles can be recognized and captured by macrophages and cleared away by the immune system, resulting in reduced drug efficacy and representing the main drawbacks. Biomimetic nanoparticles, which are coated with cell membranes from natural resources, have been applied to address this problem. This type of nanoparticle maintains some specific biological activities, allowing them to carry drugs reaching designated tissues effectively and have a longer time in circulation. This review article aims to summarize recent progress on biomimetic nanoparticles based on cell membranes. In this paper, we have introduced the classification of biomimetic nanoparticles, their preparation and characterization, and their applications in inflammatory diseases and malignant tumors. We have also analyzed the shortcomings and prospects of this technology, hoping to provide some clues for basic researchers and clinicians engaged in this field.
Identifiants
pubmed: 39472940
doi: 10.1186/s40001-024-02124-8
pii: 10.1186/s40001-024-02124-8
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
523Informations de copyright
© 2024. The Author(s).
Références
Open Biol. 2022 Oct;12(10):220146
pubmed: 36196535
Regen Biomater. 2020 Aug;7(4):349-358
pubmed: 32793380
Nature. 2009 Oct 29;461(7268):1287-91
pubmed: 19865173
Acta Biomater. 2021 Mar 15;123:354-363
pubmed: 33476827
Int J Mol Sci. 2021 May 21;22(11):
pubmed: 34063828
Adv Mater. 2016 Nov;28(43):9581-9588
pubmed: 27628433
Crit Rev Biochem Mol Biol. 2014 Mar-Apr;49(2):116-39
pubmed: 24410153
Nanoscale. 2013 Dec 7;5(23):11374-84
pubmed: 23827988
J Intern Med. 2014 Dec;276(6):618-32
pubmed: 25156650
Nano Res. 2018;11(10):5573-5583
pubmed: 31656553
Bioeng Transl Med. 2022 Nov 02;8(2):e10441
pubmed: 36925703
ACS Appl Mater Interfaces. 2021 Aug 4;13(30):35397-35409
pubmed: 34313104
J Hematol Oncol. 2020 Jul 16;13(1):96
pubmed: 32677994
Int J Mol Sci. 2020 Nov 13;21(22):
pubmed: 33202744
Gastroenterology. 2010 Apr;138(4):1395-405
pubmed: 20044996
ACS Nano. 2019 Feb 26;13(2):1272-1283
pubmed: 30673266
Nanoscale Horiz. 2020 Sep 1;5(9):1293-1302
pubmed: 32608425
Med J Aust. 2018 Sep 1;209(7):318-323
pubmed: 30257634
J Control Release. 2012 Jan 30;157(2):272-8
pubmed: 21867735
Drug Deliv. 2020 Dec;27(1):1562-1580
pubmed: 33118404
Biomed Pharmacother. 2016 May;80:30-41
pubmed: 27133037
Nanomedicine. 2019 Jan;15(1):13-24
pubmed: 30171903
Immunol Invest. 2014;43(7):638-52
pubmed: 24921428
Int J Mol Sci. 2020 Dec 31;22(1):
pubmed: 33396561
Mol Pharm. 2019 Mar 4;16(3):1397-1405
pubmed: 30753778
ACS Nano. 2019 Mar 26;13(3):2849-2857
pubmed: 30803232
Drug Discov Today. 2011 May;16(9-10):457-63
pubmed: 21414419
Biomater Sci. 2020 Jan 21;8(2):552-568
pubmed: 31769765
Angew Chem Int Ed Engl. 2022 Jun 13;61(24):e202203115
pubmed: 35395111
J Control Release. 2019 Apr 10;299:90-106
pubmed: 30807805
Theranostics. 2020 Aug 8;10(22):10106-10119
pubmed: 32929337
Nat Rev Cardiol. 2020 May;17(5):269-285
pubmed: 31969688
ACS Nano. 2017 Apr 25;11(4):3496-3505
pubmed: 28272874
Pharmaceuticals (Basel). 2022 Jan 27;15(2):
pubmed: 35215270
DNA Repair (Amst). 2019 Nov;83:102673
pubmed: 31387777
Front Immunol. 2021 Jul 09;12:686155
pubmed: 34305919
Carcinogenesis. 2010 Jan;31(1):37-49
pubmed: 19955394
J Leukoc Biol. 2017 Mar;101(3):785-795
pubmed: 27733572
J Gastroenterol Hepatol. 1996 Nov;11(11):1089-96
pubmed: 8985836
ACS Appl Mater Interfaces. 2016 Apr 20;8(15):9610-8
pubmed: 27039688
Lancet. 2016 Oct 22;388(10055):2023-2038
pubmed: 27156434
Chem Rev. 2015 Aug 26;115(16):8564-608
pubmed: 26259712
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
Int J Nanomedicine. 2021 Nov 10;16:7497-7515
pubmed: 34803378
ACS Nano. 2015 Jul 28;9(7):6918-33
pubmed: 26153897
Int J Pharm. 2019 Apr 20;561:244-264
pubmed: 30851391
Acta Pharm Sin B. 2018 Jan;8(1):23-33
pubmed: 29872620
Acta Pharm Sin B. 2019 Jul;9(4):675-689
pubmed: 31384529
Int J Nanomedicine. 2020 Jun 11;15:4125-4138
pubmed: 32606668
Biomaterials. 2019 Feb;192:292-308
pubmed: 30465973
Biomaterials. 2016 Dec;111:116-123
pubmed: 27728811
J Oleo Sci. 2020;69(2):123-131
pubmed: 32023579
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Jul-Aug;7(4):509-33
pubmed: 25581024
Chem Rev. 2022 Jul 13;122(13):11247-11286
pubmed: 35737882
Nature. 2015 Oct 1;526(7571):118-21
pubmed: 26374997
Mil Med Res. 2022 Oct 9;9(1):56
pubmed: 36209190
Adv Healthc Mater. 2021 Mar;10(6):e2002081
pubmed: 33586322
Adv Mater. 2018 May;30(22):e1707112
pubmed: 29656492
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Nat Nanotechnol. 2013 Jan;8(1):61-8
pubmed: 23241654
Chem Soc Rev. 2015 Oct 7;44(17):6287-6305
pubmed: 26056687
Cancers (Basel). 2019 Nov 21;11(12):
pubmed: 31766360
J Biomed Mater Res A. 2017 Feb;105(2):521-530
pubmed: 27718539
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Med Res Rev. 2022 Nov;42(6):2067-2101
pubmed: 35730121
Front Cell Dev Biol. 2023 Apr 19;11:1166916
pubmed: 37152280
J Control Release. 2016 Oct 28;240:332-348
pubmed: 26774224
Nano Lett. 2019 Jan 9;19(1):124-134
pubmed: 30521345
Lancet. 2020 Sep 5;396(10252):726-734
pubmed: 32891214
Nano Lett. 2014;14(4):2181-8
pubmed: 24673373
J Mater Chem B. 2018 Aug 7;6(29):4756-4764
pubmed: 30450208
ACS Nano. 2018 Jun 26;12(6):5121-5129
pubmed: 29771487
Nat Nanotechnol. 2016 Nov;11(11):986-994
pubmed: 27668795
Int J Biol Macromol. 2021 Nov 30;191:1175-1190
pubmed: 34606789
ACS Nano. 2017 Jun 27;11(6):5623-5632
pubmed: 28505422
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):10980-5
pubmed: 21690347
J Nanobiotechnology. 2021 Oct 21;19(1):331
pubmed: 34674712
Clin J Am Soc Nephrol. 2022 Jun;17(6):880-889
pubmed: 35551069
J Control Release. 2015 Dec 28;220(Pt B):600-7
pubmed: 26210440
Int J Pharm. 2021 Apr 1;598:120395
pubmed: 33639226
Nat Rev Mol Cell Biol. 2022 Jan;23(1):3-20
pubmed: 34611326
Langmuir. 2018 Dec 18;34(50):15343-15349
pubmed: 30441895
Biomaterials. 2017 Oct;143:29-45
pubmed: 28756194
ACS Omega. 2019 Aug 16;4(9):14092-14099
pubmed: 31497728
Acta Biomater. 2020 Mar 1;104:158-166
pubmed: 31954188
Langmuir. 2016 Apr 19;32(15):3637-44
pubmed: 27023433
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11488-11493
pubmed: 29073076
Sci Transl Med. 2015 Nov 25;7(315):315ra190
pubmed: 26606969
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
Nat Nanotechnol. 2018 Dec;13(12):1182-1190
pubmed: 30177807
ACS Nano. 2015 Dec 22;9(12):11800-11
pubmed: 26516654
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Adv Mater. 2015 Nov 25;27(44):7043-50
pubmed: 26416431
Phytother Res. 2019 Apr;33(4):1191-1198
pubmed: 30768745
Semin Cancer Biol. 2017 Dec;47:170-176
pubmed: 28838845
Int J Nanomedicine. 2009;4:99-105
pubmed: 19516888
ACS Biomater Sci Eng. 2020 Dec 14;6(12):6528-6539
pubmed: 33320610
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2214757120
pubmed: 36574680
Polymers (Basel). 2018 Sep 03;10(9):
pubmed: 30960908
Nano Lett. 2020 Jul 8;20(7):5570-5574
pubmed: 32551679
Theranostics. 2019 Oct 17;9(26):8073-8090
pubmed: 31754382
Nat Rev Immunol. 2008 Dec;8(12):911-22
pubmed: 18989317
ACS Nano. 2016 Aug 23;10(8):7738-48
pubmed: 27454827